IQ EQ FUND MANAGEMENT IRELAND Ltd boosted its stake in Endava plc (NYSE:DAVA – Free Report) by 80.0% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 30,835 shares of the company’s stock after buying an additional 13,704 shares during the period. IQ EQ FUND MANAGEMENT IRELAND Ltd owned approximately 0.05% of Endava worth $953,000 as of its most recent filing with the SEC.
Several other large investors have also recently bought and sold shares of the stock. Assetmark Inc. increased its stake in shares of Endava by 93.1% during the fourth quarter. Assetmark Inc. now owns 985 shares of the company’s stock worth $30,000 after purchasing an additional 475 shares during the period. Blue Trust Inc. increased its position in Endava by 28.5% during the 4th quarter. Blue Trust Inc. now owns 1,494 shares of the company’s stock worth $46,000 after buying an additional 331 shares during the period. GAMMA Investing LLC lifted its holdings in shares of Endava by 86.4% during the fourth quarter. GAMMA Investing LLC now owns 1,607 shares of the company’s stock worth $50,000 after buying an additional 745 shares in the last quarter. PNC Financial Services Group Inc. boosted its position in shares of Endava by 60.4% in the fourth quarter. PNC Financial Services Group Inc. now owns 4,086 shares of the company’s stock valued at $126,000 after acquiring an additional 1,538 shares during the period. Finally, Oppenheimer Asset Management Inc. acquired a new position in shares of Endava in the fourth quarter valued at about $215,000. 62.23% of the stock is owned by institutional investors.
Endava Price Performance
Shares of NYSE:DAVA opened at $20.70 on Friday. Endava plc has a one year low of $20.38 and a one year high of $38.42. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.90 and a quick ratio of 1.90. The company has a market cap of $1.22 billion, a price-to-earnings ratio of 188.18, a PEG ratio of 2.26 and a beta of 1.42. The firm has a 50 day simple moving average of $27.56 and a 200 day simple moving average of $27.97.
Analyst Ratings Changes
Several research analysts have recently commented on the stock. Morgan Stanley raised their target price on shares of Endava from $33.00 to $35.00 and gave the stock an “equal weight” rating in a report on Friday, January 31st. Susquehanna lowered their price objective on Endava from $55.00 to $50.00 and set a “positive” rating on the stock in a research note on Friday, February 21st. Finally, Needham & Company LLC cut their target price on Endava from $43.00 to $38.00 and set a “buy” rating for the company in a research report on Friday, February 21st. Four research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $39.10.
Check Out Our Latest Report on Endava
Endava Profile
Endava plc provides technology services for clients in the consumer products, healthcare, mobility, and retail verticals in North America, Europe, the United Kingdom, and internationally. It offers ideation and production services in the payments and financial services, telecommunications, media, and technology verticals; and business analysis, data analytics, program management, digital product strategy, private equity value enhancement, IT strategy, architecture, extended reality, machine learning and artificial intelligence, product design, and user experience and visual design services.
See Also
- Five stocks we like better than Endava
- How is Compound Interest Calculated?
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to SellĀ
- CD Calculator: Certificate of Deposit Calculator
- Top 3 Beverage Stocks Pouring Out Profits
- Stock Market Upgrades: What Are They?
- CarMax and Carvana: Steering the Used Car Market
Want to see what other hedge funds are holding DAVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Endava plc (NYSE:DAVA – Free Report).
Receive News & Ratings for Endava Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endava and related companies with MarketBeat.com's FREE daily email newsletter.